EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Can the response to interferon treatment be predicted in patients with chronic active hepatitis C?






Australian and New Zealand Journal of Medicine 21(3): 387-392

Can the response to interferon treatment be predicted in patients with chronic active hepatitis C?

Chronic hepatitis C infection can be suppressed by alpha -interferon, and about 20% of patients will be cured by 6 or more months' therapy. In this study of such treatment, response in terms of both short-term reduction of aminotransferase activity and long-term remission was most likely in those with mild liver disease and after acquisition by drug abuse rather than other sources. This contrasts with hepatitis B where responders generally have more severe liver disease.M.G.

(PDF 0-2 workdays service: $29.90)

Accession: 002042369

PMID: 1953524



Related references

Histologic forms of chronic hepatitis and response to interferon treatment. Clinical effectiveness of interferon alpha and beta treatment compared with chronic active viral hepatitis of various histologic grades. Minerva Medica 84(12): 681-685, 1993

Antipyrine clearance and response to interferon treatment in patients with chronic active hepatitis C. Hepatology. 22(4 Part 1): 1065-1071, 1995

Leucocitary alpha-interferon treatment reduces GHRH-induced GH response in patients with chronic active hepatitis. Journal of Hepatology 26(SUPPL 1): 308, 1997

Non response to interferon monotherapy can be predicted by probabilistic neural networks in naive patients with chronic hepatitis C. Hepatology 30(4 PART 2): 370A, 1999

Recombinant-alpha-2b-interferon treatment in patients with chronic active hepatitis: Effects on peripheral blood mononuclear cells and correlation with response. Current Therapeutic Research 56(4): 419-428, 1995

HCV viremia, genotypic analysis and response to interferon-alpha-2b treatment in patients with chronic active hepatitis C co-infected with the human immunodeficiency virus. Gastroenterology 110(4 SUPPL ): A1143, 1996

Interferon treatment of chronic viral hepatitis C in patients with co-existent autoimmune chronic active hepatitis. Hepatology 18(4 PART 2): 244A, 1993

Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B. European Journal of Medicine 1(7): 396-402, 1992

Interferon production in patients with chronic active hepatitis b during treatment with recombinant interferon alpha. Journal of Hepatology 7: S72, 1988

Treatment of nanb c chronic active hepatitis by alpha interferon comparison of response in cirrhotic and non cirrhotic patients. Journal of Hepatology 16(SUPPL 1): S50, 1992